School of Pharmaceutical Sciences (Shenzhen), Sun Yat-sen University, Shenzhen 518107, China.
School of Chinese Medicine, The Chinese University of Hong Kong, Hong Kong, China.
J Med Chem. 2020 May 14;63(9):4896-4907. doi: 10.1021/acs.jmedchem.0c00280. Epub 2020 Apr 21.
Development of new photosensitizers (PSs) with high photodynamic efficacy and minimal side effects is of great interest in photodynamic therapy (PDT). In this work, we reported several pyridine-embedded phenothiazinium (pyridophenothiazinium) dyes, which could be conveniently synthesized in a few short steps and acted as highly efficient and potent PSs to selectively localize to lysosomes and photosensitively kill cancer cells. Among them, compound , which possessed the ability of promoting intracellular reactive oxygen species (ROS) upon light irradiation by almost 40-fold higher than that of methylene blue (MB, a general phenothiazinium-based PS), exhibited a remarkable phototherapeutic index (PI = 53.8) against HT29 cancer cells, leading to eradication of large solid tumors (∼300 mm) in a xenograft mouse model without apparent side effects. These results suggest that the pyridophenothiazinium dyes developed herein, especially compound , may serve as promising lysosome-targeted PSs for efficient photodynamic antitumor therapy.
开发具有高光动力疗效和最小副作用的新型光敏剂 (PSs) 在光动力疗法 (PDT) 中具有重要意义。在这项工作中,我们报道了几种吡啶嵌入吩噻嗪 (吡啶吩噻嗪) 染料,它们可以通过几个短步骤方便地合成,并作为高效、强效的 PSs 选择性地定位于溶酶体,并光敏杀死癌细胞。其中,化合物 ,通过光照射能够将细胞内活性氧 (ROS) 的产生提高近 40 倍,比亚甲蓝 (MB,一种常见的吩噻嗪基 PS) 高,对 HT29 癌细胞表现出显著的光治疗指数 (PI = 53.8),导致异种移植小鼠模型中大的实体肿瘤 (约 300 mm) 的消除,没有明显的副作用。这些结果表明,本文开发的吡啶吩噻嗪染料,特别是化合物 ,可能作为有前途的溶酶体靶向 PSs,用于高效的光动力抗肿瘤治疗。